6SQ-11832-69133
2 vaccinations
3 coded responses
3 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 934 / CA
- Registered
- 2021-06-09
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-06-09
Registered in v-safe
-
2021-07-06
Survey response — 3 months, dose 2MedDRA: Fatigue, Menstruation delayed, Palpitations — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Severe fatigue. Heart palpitations. Missed periodsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-12
-
2021-10-05
Survey response — 6 months, dose 2MedDRA: Disturbance in attention, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tired, hard to concentrateMedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Survey response — 12 months, dose 2MedDRA: Abdominal pain, Ovarian cyst — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Abdominal pain and ovarian cystMedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-06 | Unsuccessful | |
| 2022-04-06 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Severe fatigue. Heart palpitations. Missed periods
Release 10 — 6 months, dose 2
Symptoms: Tired, hard to concentrate
Release 11 — 12 months, dose 2
Symptoms: Abdominal pain and ovarian cyst
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Ovarian cyst | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release